BNET Industries
Last Fiscal Year Sales:$35.9B
- Public
- DE
Dow Jones Description
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and improved earning power. We already successfully reorganized the Bayer Group and further streamlined our portfolio to create a new Bayer that is focused on its corporate strengths, its customers and the markets of the future. To help us achieve this goal, we then carried out a strategic realignment in order to concentrate in future on three high-potential, agile subgroups with largely independent operations: HealthCare, CropScience and MaterialScience, supported by three service companies. Our operating companies give us the access we need to the growth markets of the future. As an inventor company, we plan to continue setting trends in research-intensive areas. Innovations are the foundation for our competitiveness and our corporate growth, and thus for our success in the future. We believe our technical and commercial expertise entails a duty to contribute to sustainable development ? a principle we wholeheartedly endorse, mindful of its social, ethical and environmental elements. In awareness of our responsibilities as a corporate citizen, we define economy, ecology and social commitment as objectives of equal rank. We seek to retain society?s confidence through performance, flexibility and open communication as we work in pursuit of our overriding corporate goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.
Director, FinanceKlaus Kuhn
Number of Employees 122,100
Peer Companies
NAICS Code Plastics Material and Resin Manufacturing: 325211
Recent Events
-
CORRECTED - UPDATE 1-DuPont, Bayer settle seed lawsuits
-
Bayer MaterialScience's Baytubes® Carbon Nanotubes Contribute To The Next Wave Of ...
-
Bayer Diabetes Care Launches A1CNowR SELFCHECK, a New A1C Monitor for At-Home Use
-
Paulding woman sets sights on justice after suffering ailments blamed on Bayer birth-control pill
-
Onyx Faces Uncertain Times After Suing Drug Partner Bayer
-
Onyx Pharmaceuticals Inc files lawsuit against collaboration partner Bayer
-
Onyx files complaint against Bayer
-
UK Cost Agency Rejects Bayer Drug in Liver Cancer
-
UK cost agency rejects Bayer drug in liver cancer
-
Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors for...
-
Genzyme Q1 profit rises; Backs FY09 forecast
-
Picturing a New World: UNEP and Bayer Announce North American Winners of 2009 International Children's...
-
Israel's Ben-Gurion University in deal with Bayer
-
Genzyme Takes Bayer to Relieve Headache of Entering Seattle Biotech Hub, an Industrial Info News...
-
Bayer Materialscience Conducts Realistic Abrasion Test in an Automatic Car Wash
-
Bayer enters strategic agreement with Genzyme
-
BRIEF-Bayer says has acquired certain products of AgroGreen
-
Bayer 2008 revenue rises, profit plunges
-
SpringStar Takes Major Role on World Stage Protecting Children from Dengue Mosquitoes
News & Analysis
Filter by
bayer ag - All News and Analysis
Yaz Is Bayer's Top Seller Despite Blood Clot Suits, Ad Woes
Bayer's Yaz and Yasmin contraceptives appear to be recession- and scandal-resistant superbrands, if recent reports are to be believed. Bayer hit back at a German newspaper that reported the company was cutting back on pill production due to decreased demand. by Jim Edwards
Supreme Court Gives Bayer Victory in Cipro Patent Fight
The U.S. Supreme Court rejected an appeal by a pension fund to end "pay for delay" payments from drug companies to generic makers. In the case, Arkansas Carpenter's Health and Welfare Fund sued Bayer alleging that Bayer's payment of $398 million to Teva/Barr in return for Barr's agreement not to...
CSPI: Bayer Falsely Claimed One A Day Vitamins Prevent Prostate Cancer
Bayer has been threatened with a lawsuit by the Center for Science in the Public Interest over its claims that its One A Day vitamin product can somehow prevent prostate cancer. The CSPI claims Bayer's ads are false and deceptive because they claim that the selenium in One A Day...
Bayer Sued Over Yaz Death, Blood Clots
Attorneys in Ohio are gathering plaintiffs to sue Bayer over its Yaz birth control pill, claiming it causes potentially fatal blood clots. The suits come after Bayer reached an agreement with the FDA to run $20 million in corrective advertising after the company's TV spots misleadingly claimed the pill could...
Bayer Triggers Scare With White Powder Sent Through Mail
Bayer sent 33,561 packets of white powder through the U.S. Postal Service in a promotion for aspirin, triggering a federal alert to local emergency services. by Jim Edwards
Onyx Suit vs. Bayer Reads Like Romance Gone Wrong: "I Want My Baby Back!"
Onyx's lawsuit against Bayer over their joint venture on cancer drug Nexavar reads like a love affair gone wrong -- complete with allegations of Bayer going behind Onyx's back, cheating on the company as it concealed its intent to steal Onyx's baby. by Jim Edwards
The 10 Weirdest Drug Stories of the Month
April 2009 has come and gone, and once again it is time for BNET's roundup of the top 10 weirdest drug stories of the month. Enjoy! Bayer has a flock of sheep mow its lawn About 1450 sheep grazed Bayer's Richmond, Calif., campus last nonth, eating...
Probe: Bayer Destroyed Evidence After Fatal Explosion; Tried to Dampen Media Coverage
Bayer seems determined to make a bad situation worse for itself in the Congressional investigation of an explosion at its Institute, W.Va., crop sciences plant. Congress heard that Bayer destroyed evidence and engaged in a secrecy campaign in order to restrict media coverage and public criticism of how it handles...
Aspirin Maker Bayer Gets into the Supercar Business
Sure, the German company is best known for relieving headachesâ€"its chemist Max Hoffman synthesized aspirin in 1897â€"but the $12 billion (2008) Bayer AG is also in the material science business, and makes high-performance plastics that have long been used to make lightweight car bodies. In 1967, Bayer...
Bayer's Travel Police Banned Execs From Nice Hotels; Verbal Warnings for Transgressors
If you're a Bayer employee and you're wondering why -- since last year -- you can no longer stay at the hotels you want or take the flights that are most convenient, wonder no more. Bayer implemented a "nonmandated" travel policy to cut costs -- and woe...
Those who viewed this also viewed...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Klaus Kuhn | Director, Finance |
| Richard Pott | Director, Strategy and Human Resources |
| Wolfgang Plischke | Director, Innovation, Technology and Environment |
| Hartmut Klusik | Head, Product Supply |
| Gary S Balkema | Executive Committee Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Arthur J Higgins | Chairman, HealthCare |
| Werner Wenning | Executive Chairman |
| Klaus Kleinfeld | Board of Directors |
| Paul Achleitner | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Finance | Current |
| University of South Carolina | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Strategy and Human Resources | Current |
| University of Cologne | doctorate in physics | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Innovation, Technology and Environment | Current |
| Bayer HealthCare AG | Manager | Current |
| Bayer HealthCare AG | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Head, Product Supply | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Chairman, HealthCare | Current |
| Enzon Pharmaceuticals, Inc. | CEO | Former |
| Pharmaceutical Research and Manufacturers of America | member | Former |
| Bayer HealthCare, Animal Health Division | Chairman | Former |
| Enzon Pharmaceuticals, Inc. | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Chairman | Current |
| Henkel AG & Co. KGaA | Supervisory Board | Current |
Klaus Kleinfeld is president and chief executive officer of Alcoa. He joined the company in 2007 as president and chief operating officer and seven months later assumed CEO responsibilities. He has served on Alcoa's board of directors since 2003. Alcoa is a world leader in the production and management of a very sustainable product: aluminum. Nearly 75% of the aluminum ever produced since 1888 is still in use today. The company has been a technology leader since its beginning, providing more than 90% of the aluminum alloys used in aircraft and space flight; helping making automobiles lighter, without compromising safety or performance; manufacturing sheet that created the ultimate recyclable container, the aluminum beverage can; and providing building and construction industry materials that help further the green building movement. In addition, to serving customers in these markets, Alcoa also markets wheels, fastening systems, precision and investment castings, and building systems. The company has 97,000 employees in 34 countries. Before coming to Alcoa, Mr. Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as chief executive officer of Siemens AG starting in 2005. During his tenure, Mr. Kleinfeld presided over a dramatic transformation of the company, reshaping the company's portfolio around three high growth areas, resulting in increase of revenues and market capitalization nearly doubled. Prior to his service on the Managing Board of Siemens AG, Mr. Kleinfeld was President and Chief Executive Officer of Siemens Corporation, its U.S. arm and the company's largest region. In addition to serving on Alcoa's board, he is a member of the board of Bayer AG. On the personal front, Mr. Kleinfeld was born in Bremen, Germany and educated at the University of Goettingen and University of Wuerzburg, both in Germany. He holds a Ph.D in strategic management and master's degree in business administration. In his leisure time, he enjoys skiing, tennis, the arts and is a marathon runner. Mr. Kleinfeld resides in New York with his wife and children.
| Organization | Position | Status |
|---|---|---|
| Alcoa, Inc. | President & Chief Executive Officer | Current |
| Bayer AG | Board of Directors | Current |
| Alcoa, Inc. | Board of Directors | Current |
| Siemens AG | President & CEO | Former |
| Siemens Corporation | Chief Executive Officer | Former |
| Alcoa, Inc. | Chief Operating Officer | Former |
| Siemens Corporation | Chief Operating Officer | Former |
| Siemens AG | Chief Operations Officer, U.S. | Former |
| Siemens AG | Executive Vice President | Former |
| Siemens AG | Audit Committee Principal | Former |
| Citigroup Inc. | Board of Directors | Former |
| Siemens AG | Board of Directors | Former |
| Siemens Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Allianz SE | Executive Director, Finance | Current |
| Bayer AG | Board of Directors | Current |
| Goldman, Sachs & Co. | Vice President, Mergers & Acquisitions | Former |
| Bain & Company | Manager, Strategy Consulting | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Committee Member | Current |
| Bayer HealthCare, Animal Health Division | President, Worldwide Bayer Consumer Care Division | Former |
| Fairleigh Dickinson University | master of business administration degree | Former |
Executive News
-
A Giant Sucking Sound Lurking Beneath the Empire Index?
-
CEO presses Kremlin chief on red-tape nightmare
-
Alcoa President and CEO Klaus Kleinfeld to Present at Sanford C. Bernstein Strategic Decisions Conference
Industry Transcripts by Seeking Alpha
-
Lindsay Corporation F3Q09 (Qtr End 05/31/09) Earnings Call Transcript
on Jul 01, 2009about LNN
-
Nike F4Q09 (Qtr End 5/31/09) Earnings Call Transcript
on Jun 24, 2009about NKE
-
Commercial Metals Company F3Q09 (Qtr End 05/31/09) Earnings Call Transcript
on Jun 23, 2009about CMC
-
Steelcase Inc. F1Q10 (Qtr End 05/29/09) Earnings Call Transcript
on Jun 23, 2009about SCS
-
Actuant Corporation F3Q09 (Qtr End 5/31/09) Earnings Call Transcript
on Jun 17, 2009about ATU
Glass Door
Bayer AG
IndustryTop Rated
- Was N.Y. Post's Carlucci the Reason for News America Marketing's Settlement With Floorgraphics? 60 votes
- News America Marketing Whistleblower: Clients Were Charged for Ads That Never Appeared 47 votes
- News America Marketing's Alleged Plans to Seize Safeway Account Outlined in Suit 44 votes
- Compete: Twitter Passes New York Times 40 votes
- News America Marketing Group Buys Floorgraphics Just Hours After Settling Spying Lawsuit 29 votes
